Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: TripleT who wrote (49431)	1/12/2000 11:58:00 AM
From: TripleT	Read Replies (1) \| Respond to of 122087

My apologies for the last post. It was garbled and did not say what I really meant. To: Anthony@Pacific who wrote (49427) From: TripleT Wednesday, Jan 12, 2000 11:44 AM ET Reply # of 49433 Anthony, no one can say for certain. However, I've served on government review boards before and can say that they like to have all their questions answered and can be very obstinate if the applicant balks. The FDA panel rejected the SNRS data because of two reasons 1. The test results are really dismal if you look at some of the statistics. The regression is just a company smoke screen to cover up the fact that the doctors set out for "some improvement" vrs "correct the eyesight". Hence the slide that stated "properly managed expectation". Believe it or not, it was there on the SNRS website. It as well as all the potentially damaging pages were removed by the company. 2. The company did not provide enough eyes (translate test data) so that a proper evaluation could be made. My guess is that the panel will reject this data for the following reasons. a. Efficacy is still not proved by test results. b. Board did not get the number of "eyes requested". The "eyes" submitted will still show a low efficacy per no. 1. c. The "long" smoke screen about the new panel members is wrong. There will be more detailed files for them to review than was made public. I'm not currently short the stock. Any tips on how to play this thing if the application fails? Shorting is going to impossible Friday morning and I've read that the stock will be stopped Thursday because of the review. Thanks in advance TTT